This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
BRACAnalysis -2
{
"resourceType": "Observation",
"id": "ob-genetics-3-2",
"text": {
"status": "generated",
"div": "<div><p><b>Generated Narrative with Details</b></p><p><b>id</b>: ob-genetics-3-2</p><p><b>status</b>: final</p><p><b>code</b>: BRCA2 gene mutation analysis <span>(Details : {LOINC code '38530-2' = 'BCRA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal', given as 'BRCA2 gene mutation analysis'})</span></p><p><b>subject</b>: <a>Marry Chalmers(MRN: 12345)</a></p><p><b>effective</b>: 26/05/2015 3:30:10 PM</p><p><b>value</b>: Positive <span>(Details : {SNOMED CT code '10828004' = '10828004', given as 'Positive'})</span></p><p><b>method</b>: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc <span>(Details : {http://www.ncbi.nlm.nih.gov/gtr/ code 'GTR000521311.1' = '??', given as 'BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc'})</span></p><h3>Components</h3><table><tr><td>-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td>*</td><td>Genetic disease sequence variation interpretation <span>(Details : {LOINC code '53037-8' = 'Genetic disease sequence variation interpretation [interpretation] in Blood or Tissue by Molecular genetics method', given as 'Genetic disease sequence variation interpretation'})</span></td><td>Pathogenic <span>(Details : {[not stated] code 'LA6668-3' = '??', given as 'Pathogenic'})</span></td></tr></table></div>"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/observation-geneticsSequence",
"valueReference": {
"reference": "#off2"
}
},
{
"extension": [
{
"url": "genomeBuild",
"valueCodeableConcept": {
"text": "GRCh 38"
}
},
{
"url": "name",
"valueCodeableConcept": {
"text": "185delAG"
}
}
],
"url": "http://hl7.org/fhir/StructureDefinition/observation-geneticsVariationHGVS"
}
],
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "38530-2",
"display": "BRCA2 gene mutation analysis"
}
]
},
"subject": {
"reference": "Patient/example",
"display": "Marry Chalmers(MRN: 12345)"
},
"effectiveDateTime": "2015-05-26T15:30:10+01:00",
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "10828004",
"display": "Positive"
}
]
},
"method": {
"coding": [
{
"system": "http://www.ncbi.nlm.nih.gov/gtr/",
"code": "GTR000521311.1",
"display": "BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc"
}
]
},
"component": [
{
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "53037-8",
"display": "Genetic disease sequence variation interpretation"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"code": "LA6668-3",
"display": "Pathogenic"
}
]
}
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.